How the ImmunoINSIGHTS platform is typically used
Strategy of developing preferred supplier agreements with the world’s top BioPharmas
The division's H1 performance & expected growth trajectory for the rest of the year
Possible M&A opportunities
Does the group need to consider strengthening its balance sheet?
Update on the EarlyCDT lung cancer test
Why is the yearend being changed from May to Aug?
Future newsflow
Typical contract values/duration
Size of orderbook
